Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

12,409 total articles

Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Nurix Therapeutics Announces Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunology and Neurology

Nurix Therapeutics has announced a global collaboration with Roche to co-develop and co-commercialize bexobrutideg, a promising oral BTK degrader drug candidate. The deal includes a $700 million upfront payment to Nurix with potential milestones totaling up to $2.3 billion. The partnership aims to advance clinical development in malignant hematolog…

WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace

WISeKey, The Hashgraph Group and Hedera Launch QAIT Q-Day Security Assessment Platform on the SEALCOIN Quantum Marketplace

WISeKey International Holding Ltd, along with The Hashgraph Group and Hedera, has launched the QAIT Q-Day Security Assessment Platform within the SEALCOIN Quantum Marketplace. This pioneering service enables organizations to assess and prepare for cybersecurity risks introduced by advancing quantum computing, combining AI, blockchain, and post-quan…

Rumble Announces Final Results of Exchange Offer for Northern Data

Rumble Announces Final Results of Exchange Offer for Northern Data

Rumble Inc. announced the successful completion of its exchange offer to acquire Northern Data AG, securing approximately 85% of outstanding shares. The transaction is expected to close mid-June 2026, leading to the delisting of Northern Data from the Munich stock exchange. This acquisition aims to create a leading independent AI computation, cloud…

Solidion Technology Announces $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules

Solidion Technology Announces $35 Million Private Placement of Common Stock Priced Above Market Under Nasdaq Rules

Solidion Technology Inc. announced a $35 million private placement of common stock priced above market under Nasdaq rules, fully funding the company through 2028. The proceeds will accelerate commercialization of its patented Extreme-Climate Battery technology targeting the lunar economy, space applications, AI data centers, electric vehicles, and …

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

LENZ Therapeutics announces that Everest Medicines has acquired the rights from Corxel Pharmaceuticals to develop, manufacture, and commercialize VIZZ® (LNZ100) in Greater China. This strategic move positions LENZ to benefit from up to $85 million in regulatory and sales milestones plus royalties, as the first FDA-approved aceclidine-based eye drop…

Odysight.ai® Establishes At-The-Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility

Odysight.ai® Establishes At-The-Market (ATM) Program of up to $20 Million to Enhance Financial Flexibility

Odysight.ai has established an At-The-Market (ATM) program authorizing the company to sell up to $20 million in common stock through Roth Capital Partners. This strategic move aims to provide the company with flexible financing options to support ongoing business development and capitalize on market opportunities without obligating immediate share …

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders

GoHealth, Inc., a Medicare-focused digital health insurance marketplace, has voluntarily filed for Chapter 11 bankruptcy with unanimous lender support to implement a restructuring plan. The plan transitions ownership to lenders, reinstates preferred equity, assures full payment of trade obligations, intends to maintain uninterrupted business operat…

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Senseonics Holdings, Inc. reported new real-world data at the American Diabetes Association Scientific Sessions showcasing the strong performance and patient adherence of its Eversense 365 implantable continuous glucose monitoring (CGM) system. The data from over 12,000 sensors confirm sustained accuracy and positive glycemic outcomes over a full y…

All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration

All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration

All In FutureTech Alliance (Nasdaq: AIFA) provided a strategic update on accelerating its transformation into an AI infrastructure platform leveraging optical technologies. Key developments include expanding the Hainan AIFA Silicon Photonics Supercomputing Center project into a broader Digital Industrial Park, progressing in governmental approvals …

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Cullinan Therapeutics reported initial Phase 1 clinical data for CLN-978, a CD19xCD3 T cell engager, showing clinical benefit including remissions in patients with refractory systemic lupus erythematosus (SLE) and difficult-to-treat rheumatoid arthritis (RA). Data demonstrated deep, dose-dependent B cell depletion in blood and tissue along with a f…

InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering

InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering

InterPrivate Investment Partners V, Inc., a blank check company focused on mergers and acquisitions, has closed its initial public offering of 20,125,000 units at $10 per unit, raising $201.25 million before expenses. The units began trading on Nasdaq under the ticker symbol IPVVU, with plans to list their Class A shares and warrants separately in …

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics has closed an $8.5 million private placement priced at-the-market on Nasdaq, with potential to raise an additional $15.2 million through warrant exercises. The proceeds are expected to extend the company's cash runway into Q1 2027, supporting FDA submission and subsequent commercialization of its near-patient sepsis testing prod…

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems

MannKind Corporation announced new clinical and real-world data on Afrezza, its inhaled insulin product, at the ADA 2026 Scientific Sessions. The data build on the recent FDA approval for pediatric use and highlight Afrezza’s safety, efficacy, and patient treatment satisfaction in children, adolescents, and gestational diabetes patients. Additional…

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

Biomea Fusion presented promising clinical and translational data for its oral menin inhibitor icovamenib at the ADA 86th Scientific Sessions, demonstrating benefits in type 1 and type 2 diabetes including improved insulin secretion, glycemic control, muscle preservation, and fat reduction. Additionally, the company announced expansion of its Phase…

Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Decrease in May 2026 of 4.1% Compared to 2025

Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Decrease in May 2026 of 4.1% Compared to 2025

Grupo Aeroportuario del Pacifico, which operates 12 airports in Mexico and two in Jamaica, reported a 4.1% decrease in total passenger traffic in May 2026 compared to May 2025. The decline was driven by decreases at key airports including Puerto Vallarta, Tijuana, Los Cabos, and Montego Bay, despite a passenger increase at Guadalajara airport. Avai…

Caliber Announces CFO Transition

Caliber Announces CFO Transition

Caliber (Nasdaq: CWD), a real estate and digital asset management platform, announced the departure of long-time CFO Jade Leung and appointed Michael Rosales as Acting CFO effective June 14, 2026. The company reaffirmed its 2026 financial guidance and emphasized that the CFO transition will not impact its strategy or outlook. A search for a permane…

dLocal to Report Second Quarter 2026 Financial Results

dLocal to Report Second Quarter 2026 Financial Results

dLocal Limited, a cross-border payment platform focused on emerging markets, announced it will release its second quarter 2026 financial results on August 13, 2026, followed by a conference call and webcast. The company facilitates global payment infrastructures connecting enterprises to local markets in Africa, Asia, the Middle East, and Latin Ame…